Bexarotene-13C6
Bexarotene-13C6 (LGD1069-13C6) is 13C labeled Bexarotene. Bexarotene (LGD1069) is a high-affinity and selective retinoid X receptors (RXR) agonist with EC50s of 33, 24, 25 nM for RXRα, RXRβ, and RXRγ, respectively. Bexarotene shows limited affinity for RAR receptors (EC50 >10000 nM) [1][2][3]. Bexarotene can be used for the research of cutaneous T-cell lymphoma.
Product Specifications
Product Name Alternative
LGD1069-13C6
UNSPSC
12352005
Target
Autophagy; Isotope-Labeled Compounds; RAR/RXR
Related Pathways
Autophagy; Metabolic Enzyme/Protease; Others; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC1(C2=C(C(C)(CC1)C)C=C(C(C([13C]3=[13C][13C]=[13C]([13C]=[13C]3)C(O)=O)=C)=C2)C)C
Molecular Formula
C18 13C6H24O2
Molecular Weight
350.40
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Nathalia Rodrigues de Almeida, et al. A review of the molecular design and biological activities of RXR agonists. Med Res Rev. 2019 Jul;39 (4) :1372-1397.|[3]Danyang Shen, et al. Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer. Onco Targets Ther. 2019 Sep 24;12:7877-7886.|[4]Y Wang, et al. Prevention of lung cancer progression by bexarotene in mouse models. Oncogene. 2006 Mar 2;25 (9) :1320-9.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740676-100 1x 100 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741284-100 1x 100 µL
CD11c (Dendritic Cell Marker) (ITGAX/1284), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880768-100 1x 100 µL
GnRH-Receptor (LHRH Receptor) (GNRHR/768), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 